Colonoscopic screening and follow-up in patients with acromegaly: A multicenter study in Italy

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 1, 2005, Pages 84-90

  Terzolo, Massimo ^a,f   Reimondo, Giuseppe ^a   Gasperi, Maurizio ^c   Cozzi, Renato ^d   Pivonello, Rosario ^b   Vitale, Giovanni ^b   Scillitani, Alfredo ^e   Attanasio, Roberto ^d   Cecconi, Elisabetta ^c   Daffara, Fulvia ^a   Gaia, Ezio ^a   Martino, Ennio ^c   Lombardi, Gaetano ^b   Angeli, Alberto ^a   Colao, Annamaria ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e Div ed Unita di Ric di Endocrinol   (Italy)

^f ASO San Luigi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADENOMA; ADULT; ARTICLE; CANCER RISK; CARCINOMA; COLON TUMOR; COLONOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR RECURRENCE;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLONOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 19944428307     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0240     Document Type: Article

References (59)

1. Melmed S 1990 Acromegaly. N Engl J Med 322:966-977
2. Colao A, Lombardi G 1998 Growth-hormone and prolactin excess. Lancet 352:1455-1461
3. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
4. Melmed S, Jackson I, Kleinberg D, Klibanski A 1998 Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 83:2646-2652
5. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE 2000 The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244
6. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625
7. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo DB, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
8. Wolk A, Mantzoros CS, Andereson SO, Bergstrom R, Signorello LB, Lagiou B, Adami HO, Trichopoulos D 1998 Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90:911-915
9. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
10. Bustin SA, Jenkins PJ 2001 The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 7:447-454
11. Le Marchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, Wilkens LR 2002 Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. J Natl Cancer Inst 94:454-460
12. Swerdlow AJ, Higgins CD, Adlard P, Preece MA 2002 Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360:273-277
13. Wright AD, Hill DM, Lowy C, Fraser TR 1970 Mortality in acromegaly. Q J Med 39:1-16
14. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R 1980 Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12:71-79
15. Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B 1988 Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327-335
16. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni Jr JF 1991 Acromegaly and gastrointestinal cancer. Cancer 68:1673-1677
17. Barzilay J, Heatley GJ, Cushing GW 1991 Benign and malignant tumors in patiens with acromegaly. Arch Intern Med 151:1629-1632
18. Nabarro JD 1987 Acromegaly. Clin Endocrinol (Oxf) 26:481-512
19. Cheung NW, Boyages SC 1997 Increased incidence of neoplasia in females with acromegaly. Clin Endocrinol (Oxf) 47:323-327
20. Orme SM, McNally RJ, Cartwright RA, Belchetz PE 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730-2734
21. Jenkins PJ, Besser M 2001 Acromegaly and cancer: a problem. J Clin Endocrinol Metab 86:2935-2941
22. Klein I, Parveen G, Gavaler JS, Vanthiel DH 1982 Colonic polyps in patients with acromegaly. Ann Intern Med 97:27-30
23. Ituarte EM, Petrini J, Hershaman JM 1984 Acromegaly and colon cancer. Ann Intern Med 101:627-628
24. Pines A, Rozen P, Ron E, Gilat T 1985 Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 80:266-269
25. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni Jr JF 2002 Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13:395-400
26. Ezzat S, Strom C, Melmed S 1991 Colon polyps in acromegaly. Ann Intern Med 114:754-755
27. Vasen HF, van Erpecum KJ, Roelfsema F, Raue F, Koppeschaar H, Griffioen G, van Berge Henegouwen GP 1994 Increased prevalence of colonic adenomas in patients with acromegaly. Eur J Endocrinol 131:235-237
28. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M 1997 Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) 47:17-22
29. Terzolo M, Tappero G, Borretta G, Asnaghi G, Pia A, Reimondo G, Boccuzzi A, Cesario F, Rovero E, Paccotti P, Angeli A 1994 High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age. Arch Intern Med 154:1272-1276
30. Colao A, Balzano A, Ferone D, Panza N, Grande G, Marzullo P, Bove A, Iodice G, Merola B, Lombardi G 1997 Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf) 47:23-28
31. Delhougne B, Deneux C, Abs R, Chanson P, Fierens H, Laurent-Puig P, Duysburgh I, Stevenaert A, Tabarin A, Delwaide J 1995 The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Natl Cancer Inst 80:3223-3226
32. Ortego J, Vega B, Sampedro J, Escalada J, Boixeda D, Varela C 1994 Neoplastic colonic polyps in acromegaly. Horm Metab Res 26:609-610
33. Ladas SD, Thalassinos NC, Ioannides G, Raptis SA 1994 Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours? Clin Endocrinol (Oxf) 41:597-601
34. Renehan AG, Bhaskar P, Painter JE, O'Dwyer ST, Haboubi N, Vanna J, Ball SG, Shalet SM 2000 The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3417-3424
35. Jenkins PJ, Frajese V, Jones AM, Camacho-Hubner C, Lowe DG, Fairclough PD, Chew SL, Grossman AB, Monson JP, Besser GM 2000 Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3218-3221
36. Wass JAH 2003 Dynamic testing in the diagnosis and follow-up of patients with acromegaly. J Endocrinol Invest 26(Suppl 7):48-53
37. Talley NJ, Spiller R 2002 Irritable bowel syndrome: a little understood organic bowel disease? Lancet 360:555-564
38. Konishi F, Morson BC 1982 Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 35:830-841
39. Melmed S 2001 Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86:2929-2934
40. Jenkins PJ, Fairclough PD 2001 Colorectal neoplasia in acromegaly. Clin Endocrinol (Oxf) 55:727-729
41. Atkin WS 2001 Risk of colorectal neoplasia in acromegaly: an independent view. Clin Endocrinol (Oxf) 55:723-725
42. Renehan AG, Odwyer ST, Shalet SM 2001 Screening colonoscopy for acromegaly in perspective. Clin Endocrinol (Oxf) 55:731-733
43. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE 2000 A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9:345-349
44. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E 2000 Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592-1600
45. Juul A, Pedersen SA, Sorensen S, Winkler K, Jorgensen JO, Christiansen JS, Skakkebaek NE 1994 Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. Eur J Endocrinol 131:41-49
46. Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minuto F, Giordano G, Delitala G, Camanni F 1999 Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol 276:E1009-E1013
47. Giovannucci E, Pollak M 2002 Risk of cancer after growth-hormone treatment. Lancet 360:268-269
48. Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, Givel JC 1994 Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 58:452-459
49. Simmons JG, Pucilowska JB, Lund PK 1999 Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors. Am J Physiol 276: G817-G827
50. Cats A, Dullaart RP, Kleibeuker JH, Kuipers F, Sluiter WJ, Hardonk MJ, de Vries EG 1996 Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 56:523-526
51. Durrant LG, Watson SA, Hall A, Morris DL 1991 Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor α and insulin like growth factor-1. Br J Cancer 63:67-70
52. Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N 1992 Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α. Br J Cancer 65:341-346
53. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zone S, Simic M, Penezic Z, Marinkovic J; Pituitary Study Group 1998 Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol (Oxf) 49:441-445
54. Lieberman DA, de Garmo PL, Fleischer DE, Eisen GM, Chan BK, Helfand M 2000 Colonic neoplasia in patients with nonspecific GI symptoms. Gastrointest Endosc 51:647-651
55. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF 2000 Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343:169-174
56. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G 2000 Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162-168
57. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, Helper DJ, Wiersema MJ, Langefeld CD, Li W 1993 Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 88:825-831
58. van der Lely AJ, Harris AG, Lamberts SW 1992 The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clin Endocrinol (Oxf) 37:181-185
59. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, Waye JD, Bond J, Schapiro M, Stewart ET, Panish J, Ackroyd F, Kurtz R, Shike M 1993 Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328:901-906